Phase I / II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)

Leukemia advance online publication, September 1 2017.
doi:10.1038/leu.2017.242

Authors: G Bug, A Burchert, E-M Wagner, N Kröger, T Berg, S Güller, S K Metzelder, A Wolf, S Hünecke, P Bader, J Schetelig, H Serve & O G Ottmann

Source: Leukemia - September 1, 2017 Category: Hematology Authors: G Bug A Burchert E-M Wagner N Kr ö ger T Berg S G ü ller S K Metzelder A Wolf S H ü necke P Bader J Schetelig H Serve O G Ottmann Source Type: research